Dr. Fred Yang has 20 years of experience in clinical research and drug development, with expertise focusing on statistics and quantitative science. He assumed increasing responsibilities in both Big Pharma (Abbott, Pharmacia, GSK etc.) and small biotech (Discovery Labs, KBP Biosciences), overseeing biostatistics as well as trial conduct and strategic planning. He had successful end-to-end development and worldwide regulatory experiences. His therapeutic experiences range from diabetes, CV, arthritis, oncology and neonatal care, with many publications.
Fred is currently adjunct associate professor at Drexel University Medical School. He has also been involved in the grant review for Dutch Diabetes Research Foundation. Fred received his undergraduate education at Peking University and his Ph.D degree from University of Wisconsin.